These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 215799)

  • 21. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension.
    Rasmussen S; Ibsen H; Giese J
    Scand J Urol Nephrol Suppl; 1984; 79():49-52. PubMed ID: 6089319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is it time for ACE inhibitors in chronic allograft nephropathy?
    Lewis JB; Helderman JH
    Am J Kidney Dis; 2000 Jan; 35(1):154-6. PubMed ID: 10620559
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of angiotensin II antagonists in experimental hypertension.
    Bumpus FM; Smeby RR; Sweet C; Ferrario CM; Khosla MC
    Circ Res; 1973 May; 32():Suppl 1:150-8. PubMed ID: 4351356
    [No Abstract]   [Full Text] [Related]  

  • 24. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Angiotensin II inhibitors for the diagnosis and treatment of hypertension].
    Brunner HR; Gavras H
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1791-8. PubMed ID: 1013701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.
    Johnston CI; Clappison B; McGrath BP; Matthews PG; Millar JA; Anderson WP
    Prog Biochem Pharmacol; 1980; 17():123-33. PubMed ID: 6259649
    [No Abstract]   [Full Text] [Related]  

  • 27. Angiotensin II blockade and the functions of the renin-angiotensin system.
    Davis JO; Freeman RH; Watkins BE; Stephens GA; Williams GM
    Prog Biochem Pharmacol; 1976; 12():1-15. PubMed ID: 798202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of angiotensin II blockade to study adrenal steroid secretion.
    Davis JO; Freeman RH
    Fed Proc; 1976 Nov; 35(13):2508-11. PubMed ID: 976493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Angiotensin II analogue and essential hypertension].
    Kono T; Ikeda F; Oseko F; Imura H; Shimbo S; Endo J
    Nihon Rinsho; 1979 Oct; 37(10):3503-10. PubMed ID: 392137
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of the angiotensin antagonist saralasin (1-sar-8-ala-angiotensin II) on the blood pressure in secondary hypertension].
    Beckerhoff R; Vetter W; Furrer J; Tuma J; Zàruba K; Vetter H; Siegenthaler W
    Schweiz Med Wochenschr; 1976 Dec; 106(49):1738-41. PubMed ID: 1013696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Angiotensin converting enzyme inhibitors--a new group of hypotensive drugs].
    Lazowski J
    Wiad Lek; 1984 May; 37(10):792-6. PubMed ID: 6095537
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiotensin inhibitors for hypertension.
    Gavras H; Gavras I; Brunner HR
    Compr Ther; 1980 May; 6(5):14-8. PubMed ID: 6155240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Central A II-antagonism in experimental hypertension].
    Schölkens BA
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():240. PubMed ID: 565989
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical potential: angiotensin converting enzyme inhibitor or angiotensin II antagonist?
    McInnes GT
    J Hypertens Suppl; 2001 Jun; 19(1):S61-7. PubMed ID: 11451217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of blockade of angiotensin-I converting enzyme on the blood pressure of renal hypertensive rabbits.
    Romero JC; Mak SW; Hoobler SW
    Cardiovasc Res; 1974 Sep; 8(5):681-7. PubMed ID: 4373168
    [No Abstract]   [Full Text] [Related]  

  • 36. On the pathogensis of renovascular hypertension.
    Eide I
    Scand J Clin Lab Invest; 1973 Mar; 31(2):129-32. PubMed ID: 4354731
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical application of an angiotension II analogue].
    Ogiwara T; Yamamoto T; Kumahara Y; Sakakibara S
    Nihon Rinsho; 1973 Dec; 31(12):3552-5. PubMed ID: 4364961
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of angiotensin II antagonist on hypoxemia].
    Sakio H; Oode H; Taneyama C; Mita H; Usui Y; Nagayama T; Okuda C
    Masui; 1985 Jul; 34(7):973-7. PubMed ID: 4057548
    [No Abstract]   [Full Text] [Related]  

  • 39. Dosing angiotensin II blockers--beyond blood pressure.
    Peters H; Ritz E
    Nephrol Dial Transplant; 1999 Nov; 14(11):2568-70. PubMed ID: 10534487
    [No Abstract]   [Full Text] [Related]  

  • 40. [Diagnostic value of angiotensin II analogue].
    Fukiyama K
    Nihon Rinsho; 1978 May; Suppl():2310-1. PubMed ID: 691741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.